Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02729545Phase 2Completed
Phase 2, randomised, open-label trial (2 arms), sponsored by Beijing Integrated Traditional and Western Medicine Hospital. Primary endpoint: Change in Luteinizing Hormone/Follicle-Stimulating Hormone Ratio at 12 weeks. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02729545.